Funding Update

AI SummaryClose X

Trellus Health plc has secured a US$50,000 unsecured loan from CEO and Co-Founder Dr. Marla Dubinsky, bearing 5% annual interest and maturing in 12 months, which extends the company's cash runway into late April 2026. While a convertible facility remains available, its utilization is constrained by market conditions. The company's Independent Directors, in consultation with its Nominated Adviser, deem the terms of this related party transaction fair and reasonable for shareholders, as Trellus Health continues to explore further funding options to support its commercial strategy.

Disclaimer*

UK 100

Latest directors dealings